Transient benefits but lack of protection by sodium pyruvate after 2-hour middle cerebral artery occlusion in the rat

Brain Research

Volumn 1272, Issue , 2009, Pages 45-51

  Martín, Abraham ^a   Rojas, Santiago ^a   Pérez Asensio, Fernando ^a   Planas, Anna M ^a  

^a INST D INVESTIGACIONS B   (Spain)

Author keywords

ATP; Brain; Infarction; Ischemia; Pyruvate

Indexed keywords

ADENOSINE TRIPHOSPHATE; PYRUVATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME BLOOD LEVEL; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION;

ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; BRAIN INFARCTION; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; PYRUVIC ACID; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 67349132845     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.03.056     Document Type: Article

References (20)

1. Das U.N. Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule. Med. Sci. Monit. 12 (2006) RA79-84
2. Desagher S., Glowinski J., and Premont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 17 (1997) 9060-9067
3. Folbergrova J., Zhao Q., Katsura K., and Siesjö B.K. N-tert-butyl-alpha-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 5057-5061
4. Frenzel J., Richter J., and Eschrich K. Pyruvate protects glucose-deprived Müller cells from nitric oxide-induced oxidative stress by radical scavenging. Glia 52 (2005) 276-288
5. González-Falcón A., Candelario-Jalil E., García-Cabrera M., and León O.S. Effects of pyruvate administration on infarct volume and neurological deficits following permanent focal cerebral ischemia in rats. Brain Res. 990 (2003) 1-7
6. Hata R., Maeda K., Hermann D., Mies G., and Hossmann K.A. Evolution of brain infarction after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 20 (2000) 937-946
7. Justicia C., Pérez-Asensio F.J., Burguete M.C., Salom J.B., and Planas A.M. Administration of transforming growth factor-alpha reduces infarct volume after transient focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 21 (2001) 1097-1104
8. Justicia C., Martín A., Rojas S., Gironella M., Cervera A., Panés J., Chamorro A., and Planas A.M. Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice. J. Cereb. Blood Flow Metab. 26 (2006) 421-432
9. Kim J.B., Yu Y.M., Kim S.W., and Lee J.K. Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res. 1060 (2005) 188-192
10. Lee J.Y., Kim Y.H., and Koh J.Y. Protection by pyruvate against transient forebrain ischemia in rats. J. Neurosci. 21:RC171 (2001) 1-6
11. Millar L.P., and Oldendorf W.H. Regional kinetic constants for blood-brain barrier pyruvic acid transport in conscious rats by the monocarboxylic acid carrier. J. Neurochem. 46 (1986) 1412-1416
12. Petegnief V., Font-Nieves M., Martin M.E., Salinas M., and Planas A.M. Nitric oxide mediates NMDA-induced persistent inhibition of protein synthesis through dephosphorylation of eukaryotic initiation factor 4E-binding protein 1 and eukaryotic initiation factor 4G proteolysis. Biochem. J. 411 (2008) 667-677
13. Phillis J.W., Ren J., and O'Regan M.H. Studies on the effects of lactate transport inhibition, pyruvate, glucose and glutamine on amino acid, lactate and glucose release from the ischemic rat cerebral cortex. J. Neurochem. 76 (2001) 247-257
14. Rojas S., Martín A., Justicia C., Falcón C., Bargalló N., Chamorro A., and Planas A.M. Modest MRI signal intensity changes precede delayed cortical necrosis after transient focal ischemia in the rat. Stroke 37 (2006) 1525-1532
15. Sharma A.B., Barlow M.A., Yang S.H., Simpkins J.W., and Mallet R.T. Pyruvate enhances neurological recovery following cardiopulmonary arrest and resuscitation. Resuscitation 76 (2008) 108-119
16. Sims C.A., Wattanasirichaigoon S., Menconi M.J., Ajami A.M., and Fink M.P. Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit. Care Med. 29 (2001) 1513-1518
17. 14C-glucose by neurons and astrocytes in brain subregions following focal cerebral ischemia in rats. J. Neurochem. 97 (2006) 968-978
18. Tokumaru O., Kuroki C., Yoshimura N., Sakamoto T., Takei H., Ogata K., Kitano T., Nisimaru N., and Yokoi I. Neuroprotective effects of ethyl pyruvate on brain energy metabolism after ischemia-reperfusion injury: a (31)P-nuclear magnetic resonance study. Neurochem. Res. (2008) Nov 5. [Electronic publication ahead of print]
19. Yi J.S., Kim T.Y., Kyu Kim D., and Koh J.Y. Systemic pyruvate administration markedly reduces infarcts and motor deficits in rat models of transient and permanent focal cerebral ischemia. Neurobiol. Dis. 26 (2007) 94-104
20. Yu Y.M., Kim J.B., Lee K.W., Kim S.Y., Han P.L., and Lee J.K. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window. Stroke 36 (2005) 2238-2243